Plexiform Neurofibromas Treatment Market, by Drug Class (Selumetinib, Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), Anticonvulsants, Others (Tricyclic Antidepressants, etc.)), by Patient Population (Pediatric, Adult), by Distribution Channel (Hospital P

Plexiform Neurofibromas Treatment Market, by Drug Class (Selumetinib, Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), Anticonvulsants, Others (Tricyclic Antidepressants, etc.)), by Patient Population (Pediatric, Adult), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)- Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030

Plexiform neurofibromas is an uncommon variant of neurofibromatosis type 1 that arises from multiple nerves as bulging and deforming masses involving also connective tissue and skin folds. Neurofibromatosis is a genetic neurological disorder which can affect the skin, nerves, brain, and spinal cord. Neurofibromas or tumors, grow along the body's nerves or on or underneath the skin. There are three types of neurofibromatosis that are associated with unique symptoms and signs, Neurofibromatosis type 1 (NF1), Neurofibromatosis type 2 (NF2), and Schwannomatosis. Plexiform neurofibromas are essentially pathognomonic of neurofibromatosis type 1 (NF1) which is a common complication of neurofibromatosis. Plexiform neurofibromas are predominantly inherited tumors that can occur anywhere in the body. This includes the head and neck, extremities, areas around the spine and deep in the body where they may affect organs. Plexiform neurofibromas are usually diagnosed in early childhood. They are found in approximately 30% of patients with NF1. Plexiform neurofibromas diffusely involve long nerve segments and its branches, often extending beyond the epineurium into the surrounding tissue.

Market Dynamics

Adoption of inorganic strategies, such as product approval, by regulatory authority such as the U.S. Food and Drug Administration is expected to drive the global plexiform neurofibromas treatment market growth over the forecast period. For instance, in April 2020, AstraZeneca, a biopharmaceutical company, announced that they had received an approval from the U.S. Food and Drug Administration for Selumetinib under the brand name Koselugo, for pediatric patients, 2 years of age and older, with neurofibromatosis type 1. Selumetinib is a kinase inhibitor and the first therapy approved for pediatric patients with neurofibromatosis.

Key features of the study:

  • This report provides an in-depth analysis of the global plexiform neurofibromas treatment market, and provides market size (US$ Million) and compound annual growth rate (CAGR%) for the forecast period (2022–2030), considering 2021 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global plexiform neurofibromas treatment market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies
  • Key companies covered as a part of this study include AstraZeneca, Pfizer Inc., Sun Pharmaceuticals Industries Limited, Mallinckrodt Pharmaceuticals, SpringWorks Therapeutics, Alcaliber S.A, Teva Pharmaceutical Industries Ltd., Glenmark, Amneal Pharmaceuticals LLC, Aurobindo Pharma, Apotex Inc., Mylan N.V., GSK plc., Solara Active Pharma Sciences Ltd., Abbott, Shanghai Kechow Pharma, Inc., Endo Pharmaceuticals Inc., Purdue Pharma L.P, Merck & Co., Inc., NFlection Therapeutics, Healx, and Array Biopharma
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • The global plexiform neurofibromas treatment market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global plexiform neurofibromas treatment market
Detailed Segmentation:
  • Global Plexiform Neurofibromas Treatment Market, By Drug Class:
  • Selumetinib
  • Non-Steroidal Anti-Inflammatory Drugs (NSAIDs)
  • Anticonvulsants
  • Others (Tricyclic Antidepressants, etc.)
  • Global Plexiform Neurofibromas Treatment Market, By Patient Population:
  • Pediatric
  • Adult
  • Global Plexiform Neurofibromas Treatment Market, By Distribution Channel:
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • Global Plexiform Neurofibromas Treatment Market, By Region:
  • North America
  • By Country
  • U.S.
  • Canada
  • Latin America
  • By Country
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
  • Europe
  • By Country
  • Germany
  • U.K.
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe
  • Asia Pacific
  • By Country
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
  • Middle East
  • By Country
  • GCC
  • Israel
  • Rest of Middle East
  • Africa
  • By Region/Country
  • South Africa
  • Central Africa
  • North Africa
  • Company Profiles
  • AstraZeneca*
  • Company Highlights
  • Products Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
  • Pfizer Inc.
  • Sun Pharmaceuticals Industries Limited
  • Mallinckrodt Pharmaceuticals
  • SpringWorks Therapeutics
  • Alcaliber S.A
  • Teva Pharmaceutical Industries Ltd.
  • Glenmark
  • Amneal Pharmaceuticals LLC
  • Aurobindo Pharma
  • Apotex Inc.
  • Mylan N.V.
  • GSK plc.
  • Solara Active Pharma Sciences Ltd.
  • Abbott
  • Shanghai Kechow Pharma, Inc.
  • Endo Pharmaceuticals Inc.
  • Purdue Pharma L.P
  • Merck & Co., Inc.
  • NFlection Therapeutics
  • Healx
  • Array Biopharma
“*” marked represents similar segmentation in other categories in the respective section.


1. Research Objectives and Assumptions
Research Objectives
Assumptions
Abbreviations
2. Market Purview
Report Description
Market Definition and Scope
Executive Summary
Market Snapshot, By Drug Class
Market Snapshot, By Patient Population
Market Snapshot, By Distribution Channel
Market Snapshot, By Region
Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
Market Dynamics
Drivers
Restraints
Market Opportunities
Impact Analysis
Market Trends
PEST Analysis
PORTER’s Analysis
Key Developments
Brand Analysis
Merger and Collaboration Scenario
Epidemiology
Product Approvals/Launches
Treatment Algorithm
Treatment Option Analysis
Site of Activity (Mode of Action)
New Investments by Major Market Players
Manufacturer Revenue
Disease Awareness Programs
Healthcare Spending by Country
4. Global Plexiform Neurofibromas Treatment Market- Impact of Coronavirus (Covid-19) Pandemic
COVID-19 Epidemiology
Supply Side and Demand Side Analysis
COVID-19 Impact on Overall Healthcare Sector
Impact on Clinical Trials
5. Global Plexiform Neurofibromas Treatment Market, By Drug Class, 2017 – 2030, (US$ Million)
Overview
Market Share Analysis, 2022 and 2030 (%)
Y-o-Y Growth Analysis, 2017 – 2030
Segment Trends
Selumetinib
Overview
Market Size and Forecast, and Y-o-Y Growth, 2017–2030, (US$ Million)
Non-Steroidal Anti-Inflammatory Drugs (NSAIDs)
Overview
Market Size and Forecast, and Y-o-Y Growth, 2017–2030, (US$ Million)
Anticonvulsants
Overview
Market Size and Forecast, and Y-o-Y Growth, 2017–2030, (US$ Million)
Others (Tricyclic Antidepressants, etc.)
Overview
Market Size and Forecast, and Y-o-Y Growth, 2017–2030, (US$ Million)
6. Global Plexiform Neurofibromas Treatment Market, By Patient Population, 2017 – 2030, (US$ Million)
Overview
Market Share Analysis, 2022 and 2030 (%)
Y-o-Y Growth Analysis, 2017 – 2030
Segment Trends
Pediatric
Overview
Market Size and Forecast, and Y-o-Y Growth, 2017–2030, (US$ Million)
Adult
Overview
Market Size and Forecast, and Y-o-Y Growth, 2017–2030, (US$ Million)
7. Global Plexiform Neurofibromas Treatment Market, By Distribution Channel, 2017 – 2030, (US$ Million)
Overview
Market Share Analysis, 2022 and 2030 (%)
Y-o-Y Growth Analysis, 2017 – 2030
Segment Trends
Hospital Pharmacies
Overview
Market Size and Forecast, and Y-o-Y Growth, 2017–2030, (US$ Million)
Retail Pharmacies
Overview
Market Size and Forecast, and Y-o-Y Growth, 2017–2030, (US$ Million)
Online Pharmacies
Overview
Market Size and Forecast, and Y-o-Y Growth, 2017–2030, (US$ Million)
8. Global Plexiform Neurofibromas Treatment Market, By Region, 2017 – 2030, (US$ Million)
Introduction
Market Share Analysis, By Region, 2022 and 2030 (%)
Y-o-Y Growth Analysis, For Regions, 2017–2030
Regional Trends
North America
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2017 - 2030, (US$ Million)
Market Size and Forecast, and Y-o-Y Growth, By Patient Population, 2017 - 2030, (US$ Million)
Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2030, (US$ Million)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 – 2030, (US$ Million)
U.S.
Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2017 - 2030, (US$ Million)
Market Size and Forecast, and Y-o-Y Growth, By Patient Population, 2017 - 2030, (US$ Million)
Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2030, (US$ Million)
Canada
Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2017 - 2030, (US$ Million)
Market Size and Forecast, and Y-o-Y Growth, By Patient Population, 2017 - 2030, (US$ Million)
Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2030, (US$ Million)
Latin America
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2017 - 2030, (US$ Million)
Market Size and Forecast, and Y-o-Y Growth, By Patient Population, 2017 - 2030, (US$ Million)
Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2030, (US$ Million)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 – 2030, (US$ Million)
Brazil
Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2017 - 2030, (US$ Million)
Market Size and Forecast, and Y-o-Y Growth, By Patient Population, 2017 - 2030, (US$ Million)
Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2030, (US$ Million)
Mexico
Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2017 - 2030, (US$ Million)
Market Size and Forecast, and Y-o-Y Growth, By Patient Population, 2017 - 2030, (US$ Million)
Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2030, (US$ Million)
Argentina
Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2017 - 2030, (US$ Million)
Market Size and Forecast, and Y-o-Y Growth, By Patient Population, 2017 - 2030, (US$ Million)
Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2030, (US$ Million)
Rest of Latin America
Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2017 - 2030, (US$ Million)
Market Size and Forecast, and Y-o-Y Growth, By Patient Population, 2017 - 2030, (US$ Million)
Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2030, (US$ Million)
Europe
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2017 - 2030, (US$ Million)
Market Size and Forecast, and Y-o-Y Growth, By Patient Population, 2017 - 2030, (US$ Million)
Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2030, (US$ Million)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 – 2030, (US$ Million)
U.K.
Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2017 - 2030, (US$ Million)
Market Size and Forecast, and Y-o-Y Growth, By Patient Population, 2017 - 2030, (US$ Million)
Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2030, (US$ Million)
Germany
Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2017 - 2030, (US$ Million)
Market Size and Forecast, and Y-o-Y Growth, By Patient Population, 2017 - 2030, (US$ Million)
Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2030, (US$ Million)
Italy
Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2017 - 2030, (US$ Million)
Market Size and Forecast, and Y-o-Y Growth, By Patient Population, 2017 - 2030, (US$ Million)
Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2030, (US$ Million)
France
Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2017 - 2030, (US$ Million)
Market Size and Forecast, and Y-o-Y Growth, By Patient Population, 2017 - 2030, (US$ Million)
Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2030, (US$ Million)
Spain
Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2017 - 2030, (US$ Million)
Market Size and Forecast, and Y-o-Y Growth, By Patient Population, 2017 - 2030, (US$ Million)
Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2030, (US$ Million)
Russia
Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2017 - 2030, (US$ Million)
Market Size and Forecast, and Y-o-Y Growth, By Patient Population, 2017 - 2030, (US$ Million)
Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2030, (US$ Million)
Rest of Europe
Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2017 - 2030, (US$ Million)
Market Size and Forecast, and Y-o-Y Growth, By Patient Population, 2017 - 2030, (US$ Million)
Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2030, (US$ Million)
Asia Pacific
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2017 - 2030, (US$ Million)
Market Size and Forecast, and Y-o-Y Growth, By Patient Population, 2017 - 2030, (US$ Million)
Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2030, (US$ Million)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 – 2030, (US$ Million)
China
Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2017 - 2030, (US$ Million)
Market Size and Forecast, and Y-o-Y Growth, By Patient Population, 2017 - 2030, (US$ Million)
Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2030, (US$ Million)
India
Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2017 - 2030, (US$ Million)
Market Size and Forecast, and Y-o-Y Growth, By Patient Population, 2017 - 2030, (US$ Million)
Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2030, (US$ Million)
Japan
Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2017 - 2030, (US$ Million)
Market Size and Forecast, and Y-o-Y Growth, By Patient Population, 2017 - 2030, (US$ Million)
Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2030, (US$ Million)
ASEAN
Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2017 - 2030, (US$ Million)
Market Size and Forecast, and Y-o-Y Growth, By Patient Population, 2017 - 2030, (US$ Million)
Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2030, (US$ Million)
Australia
Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2017 - 2030, (US$ Million)
Market Size and Forecast, and Y-o-Y Growth, By Patient Population, 2017 - 2030, (US$ Million)
Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2030, (US$ Million)
South Korea
Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2017 - 2030, (US$ Million)
Market Size and Forecast, and Y-o-Y Growth, By Patient Population, 2017 - 2030, (US$ Million)
Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2030, (US$ Million)
Rest of Asia Pacific
Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2017 - 2030, (US$ Million)
Market Size and Forecast, and Y-o-Y Growth, By Patient Population, 2017 - 2030, (US$ Million)
Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2030, (US$ Million)
Middle East
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2017 - 2030, (US$ Million)
Market Size and Forecast, and Y-o-Y Growth, By Patient Population, 2017 - 2030, (US$ Million)
Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2030, (US$ Million)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 – 2030, (US$ Million)
GCC
Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2017 - 2030, (US$ Million)
Market Size and Forecast, and Y-o-Y Growth, By Patient Population, 2017 - 2030, (US$ Million)
Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2030, (US$ Million)
Israel
Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2017 - 2030, (US$ Million)
Market Size and Forecast, and Y-o-Y Growth, By Patient Population, 2017 - 2030, (US$ Million)
Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2030, (US$ Million)
Rest of Middle East
Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2017 - 2030, (US$ Million)
Market Size and Forecast, and Y-o-Y Growth, By Patient Population, 2017 - 2030, (US$ Million)
Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2030, (US$ Million)
Africa
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2017 - 2030, (US$ Million)
Market Size and Forecast, and Y-o-Y Growth, By Patient Population, 2017 - 2030, (US$ Million)
Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2030, (US$ Million)
Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2017 – 2030, (US$ Million)
North Africa
Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2017 - 2030, (US$ Million)
Market Size and Forecast, and Y-o-Y Growth, By Patient Population, 2017 - 2030, (US$ Million)
Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2030, (US$ Million)
Central Africa
South Africa
9. Competitive Landscape
AstraZeneca
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Market Strategies
Pfizer Inc.
Sun Pharmaceuticals Industries Limited
Mallinckrodt Pharmaceuticals
SpringWorks Therapeutics
Alcaliber S.A
Teva Pharmaceutical Industries Ltd.
Glenmark
Amneal Pharmaceuticals LLC
Aurobindo Pharma
Apotex Inc.
Mylan N.V.
GSK plc.
Solara Active Pharma Sciences Ltd.
Abbott
Shanghai Kechow Pharma, Inc.
Endo Pharmaceuticals Inc.
Purdue Pharma L.P
Merck & Co., Inc.
NFlection Therapeutics
Healx
Array Biopharma
10. Section
Research Methodology
About Us
*Browse 113 market data tables and 50 figures on "Global Plexiform Neurofibromas Treatment Market” - forecast to 2030

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings